Tens of millions of people worldwide suffer from Alzheimer’s disease, a form of dementia. There is no cure and treatments are limited.

But a new drug that has controversially just been approved by the U.S. Food & Drug Administration is providing hope it could delay the progression of the disease, despite concerns over its efficacy.

CGTN’s Karina Huber reports.

Check out The China Report, our new weekly newsletter. Subscribe here!